melanoma (skin)
Showing 76 - 100 of 328
Melanoma (Skin) Trial in Canada (recombinant human interleukin-21, immunohistochemistry staining method, laboratory biomarker
Completed
- Melanoma (Skin)
- recombinant human interleukin-21
- +3 more
-
Edmonton, Alberta, Canada
- +6 more
Apr 6, 2020
Melanoma (Skin) Trial in Charlottesville (biological, drug, procedure)
Completed
- Melanoma (Skin)
- incomplete Freund's adjuvant
- +6 more
-
Charlottesville, VirginiaUniversity of Virginia Cancer Center
Mar 26, 2020
Melanoma (Skin) Trial in Beijing (OrienX010 injection, Dacarbazine (DTIC))
Recruiting
- Melanoma (Skin)
- OrienX010 injection
- Dacarbazine (DTIC)
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Feb 25, 2020
Immunotherapy for Melanoma With Gut Microbiome and Metabolomics
Recruiting
- Melanoma (Skin)
-
Northwood, Middlesex, United Kingdom
- +4 more
Feb 25, 2020
Melanoma (Skin), Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Taipei (Harmonic Generation Microscopy)
Unknown status
- Melanoma (Skin)
- +2 more
- Harmonic Generation Microscopy
-
Taipei, TaiwanDepartment of Dermatology, National Taiwan University Hospital a
Jan 22, 2020
Melanoma (Skin) Trial in Madison (hu14.18-IL2 fusion protein)
Completed
- Melanoma (Skin)
- hu14.18-IL2 fusion protein
-
Madison, WisconsinUniversity of Wisconsin Paul P. Carbone Comprehensive Cancer Cen
Nov 15, 2019
Melanoma (Skin) Trial in Madison (gp100 antigen, sargramostim)
Completed
- Melanoma (Skin)
- gp100 antigen
- sargramostim
-
Madison, WisconsinUniversity of Wisconsin Comprehensive Cancer Center
Nov 15, 2019
Melanoma (Skin) Trial in Baltimore (pentamidine)
Terminated
- Melanoma (Skin)
-
Baltimore, MarylandGreenebaum Cancer Center at University of Maryland Medical Cente
Aug 14, 2019
Melanoma (Skin) Trial (Microsoft Band 2 + UV messaging, Microsoft Band 2)
Withdrawn
- Melanoma (Skin)
- Microsoft Band 2 + UV messaging
- Microsoft Band 2
- (no location specified)
Apr 15, 2019
Melanoma (Skin) Trial in Rochester (MART-1 antigen, IL-2, gp100 antigen)
Completed
- Melanoma (Skin)
- MART-1 antigen
- +4 more
-
Rochester, MinnesotaMayo Clinic
Feb 15, 2019
Melanoma (Skin) Trial in Philadelphia (fenretinide, tretinoin)
Completed
- Melanoma (Skin)
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania Cancer Center
Dec 30, 2018
French Clinical Datbase of Melanoma Patients (RIC-Mel)
Unknown status
- Melanoma (Skin)
-
Nantes, FranceNantes University Hospital
Nov 20, 2018
Kidney Cancer, Melanoma (Skin), Metastatic Cancer Trial in United States (cryosurgery, radiation therapy)
Terminated
- Kidney Cancer
- +4 more
- cryosurgery
- radiation therapy
-
Birmingham, Alabama
- +6 more
Oct 26, 2018
Melanoma (Skin) Trial in Rochester (biological, other, procedure)
Completed
- Melanoma (Skin)
- sargramostim
- +7 more
-
Rochester, MinnesotaMayo Clinic Cancer Center
Oct 29, 2018
Melanoma (Skin) Trial in United States (carboplatin, paclitaxel albumin-stabilized nanoparticle formulation)
Completed
- Melanoma (Skin)
- carboplatin
- paclitaxel albumin-stabilized nanoparticle formulation
-
Scottsdale, Arizona
- +155 more
Sep 17, 2018
Melanoma (Skin) Trial in New Brunswick (hydroxychloroquine)
Completed
- Melanoma (Skin)
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Sep 20, 2018
Melanoma (Skin), Basal Cell Carcinoma of the Skin, Squamous Cell Carcinoma of the Skin Trial in Calgary (Artificial Intelligence
Unknown status
- Melanoma (Skin)
- +2 more
- Artificial Intelligence Dermatology Assistant (AIDA™)
-
Calgary, Alberta, CanadaTotal Skincare Centre
Aug 3, 2018
Melanoma (Skin), Non-melanoma Skin Cancer, Actinic Keratoses Trial in Tromsø (Nevus doctor clinical decision support)
Unknown status
- Melanoma (Skin)
- +2 more
- Nevus doctor clinical decision support
-
Tromsø, Troms, NorwayUniversity Hospital of North-Norway
Aug 6, 2018
Tumor Samples From Locally Advanced or Metastatic Melanoma
Completed
- Melanoma (Skin)
- gene expression analysis
- polymorphism analysis
- (no location specified)
Jun 27, 2018
High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic
Completed
- Kidney Cancer
- Melanoma (Skin)
- aldesleukin
- +3 more
-
Omaha, NebraskaUNMC Eppley Cancer Center at the University of Nebraska Medical
Mar 29, 2018
Melanoma (Skin) Trial in Tampa (Bystander-Based Autologous Tumor Cell Vaccine)
Completed
- Melanoma (Skin)
- Bystander-Based Autologous Tumor Cell Vaccine
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 31, 2018
Melanoma (Skin) Trial in Erlangen (Dendritic cell vaccine plus denileukin difitox)
Completed
- Melanoma (Skin)
- Dendritic cell vaccine plus denileukin difitox
-
Erlangen, GermanyDermatologische Klinik mit Poliklinik - Universitaetsklinikum Er
Feb 16, 2018